Thread by @usman_aliakbar

Aiming for #match2023 with my updated profile. Hi everyone, I am Usman. I am currently working as a research associate at the Department of Medicine, Northwell Health. I have a US clinical research experience of 18 months with 25 publications, including posters 1/3

and conference abstracts. I have experience of working on COVID-19 clinical research projects including J&J vaccine. Other prominent projects include HIV Rapid ART Study, RSV Vaccine trial and Post-Covid Clinic. I have recently been done with Step3 too. 2/3

Currently, my clinical research focus is to improve adherence to screening for barret’s esophagus. I am looking to connect with people from medical fraternity and looking for mentorship and guidance regarding next match cycle. Please retweet. Thanks 3/3 @StoriesImg @ImgJourney

I have been honored to present my two posters at @ASTCT ( American Society of Transplantation & Cellular Therapy) 2022, Salt Lake City, Utah.

https://twitter.com/usman_aliakbar/status/1519532326954409984

Adding an update : Our abstract got accepted as poster presentation in ACG 2022. @AmCollegeGastro #Match2023 #GITwitter

Resume Updatw : 1 poster @AmCollegeGastro ✅
6 abstracts @ASH_hematology ✅ #Match2023 Keep going. Pls retweet. @StoriesImg @ImgJourney @Inside_TheMatch

Resume update :
📃 Honored to be part of a multicenter retrospective study of 1645 patients hospitalized with SARS-CoV-2 PNA to know the impact of hyperglycemia on cardiovascular Events and Clinical Outcomes in Patients Hospitalized With COVID-19 PNA. doi.org/10.1016/j.epra…

Results:
🔍Of 1627 adults, 634 (39%) had a known diagnosis of type 2 diabetes, and among 993 patients with no diabetes, 107 (10.8%) patients were identified with elevated HbA1c levels and/or admission hyperglycemia.

➡️Patients with elevated HbA1c levels and/or admission hyperglycemia had increased odds of developing acute in-hospital cardiovascular events, intensive care unit admissions, and mortality (OR, 1.77; 95% CI, 1.02-3.07) compared to patients with type 2 diabetes and no diabetes.

🎯Patients with elevated HbA1c levels and/or admission hyperglycemia hospitalized with SARS-CoV-2 pneumonia have increased risk of developing acute in-hospital cardiovascular complications and overall poor clinical outcomes compared with patients with type 2 diabetes and no DM.

#Covid_19 #CovidIsNotOver #CardioTwitter #MedTwitter @StoriesImg @ImgJourney @Inside_TheMatch #Match2023 #IMG

@threadreaderapp compile